HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carcinosarcoma of the liver: a case report and review of the literature.

Abstract
No more than 11 cases of carcinosarcoma of the liver have been reported in the past 40 years that fulfill the definition of hepatocellular carcinoma combined with differentiated sarcomatous elements. Most cases consist of hepatocellular carcinoma with 1 to 2 heterologous elements. We report a case of a 51-year-old woman with liver carcinosarcoma consisting of 3 carcinomatous components and 4 sarcomatous components. Hepatocellular carcinoma, fibrolamellar type, was accompanied by neuroendocrine carcinoma (neuron-specific enolase and synaptophysin positive) and adenocarcinoma (cytokeratin 7 and 20 positive). The sarcomatous elements consisted of poorly differentiated spindle cell neoplasm (vimentin positive), leiomyosarcoma (smooth muscle actin positive), rhabdomyosarcoma (desmin positive), and osteosarcoma. To our knowledge, this is the first case of liver carcinosarcoma with this many differentiated heterologous features. There are differing views on the pathogenesis of this tumor. Findings in this case support the view that metaplasia of carcinomatous cells gives rise to the sarcomatous elements.
AuthorsRosemary She, Juliana Szakacs
JournalArchives of pathology & laboratory medicine (Arch Pathol Lab Med) Vol. 129 Issue 6 Pg. 790-3 (Jun 2005) ISSN: 1543-2165 [Electronic] United States
PMID15913431 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
Topics
  • Antineoplastic Agents (therapeutic use)
  • Benzamides
  • Carcinoma, Hepatocellular (diagnosis)
  • Carcinosarcoma (drug therapy, metabolism, secondary)
  • Diagnosis, Differential
  • Fatal Outcome
  • Female
  • Hepatorenal Syndrome
  • Humans
  • Imatinib Mesylate
  • Liver Neoplasms (drug therapy, metabolism, pathology)
  • Middle Aged
  • Piperazines (therapeutic use)
  • Pyrimidines (therapeutic use)
  • Sarcoma (diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: